Johnson & Johnson (JNJ) is currently in Stage 2: Accumulation Phase, though it is consolidating just below its 52-week high. The stock closed at $271.22 on Sept. 25, remains near the top of its annual range, trades above its 200-day average and is building a relatively tight range around $269 to $275; lighter-than-average volume indicates orderly digestion rather than an explosive breakout.

Current phase: Stage 2: Accumulation Phase

JNJ is in a constructive uptrend and is consolidating near the upper end of its 52-week range. The stock closed at $271.22 on Sept. 25, below its recent $275.23 intraday high and the $281.07 52-week high, but above the 200-day moving average. The current pattern reflects orderly consolidation rather than a parabolic Stage 3 advance.

Chart Analysis & Price Action Assessment

  • Overall trend: The intermediate- and long-term trend is bullish. JNJ is trading near the top of its 52-week range and above its 200-day moving average.
  • Recent price behavior: JNJ opened at $271.70 on Sept. 25, traded between $269.26 and $272.25, and closed at $271.22. The previous session reached an intraday high of $275.23 before closing near $270.68.
  • Range behavior: The stock is consolidating in a tight $269 to $275 area after moving higher through prior resistance. Buyers have continued to defend the upper-$260s while sellers have emerged near $273 to $276.
  • Candlestick behavior: Recent daily bars are moderate in size and largely overlapping. The Sept. 24 upper wick near $275.23 indicates supply above $273 to $275, but the stock has not shown a significant breakdown.
  • Trend strength: The pattern remains constructive while JNJ holds above the $266 to $269 support region. A sustained close above $275.55 would improve the odds of a retest of the 52-week high.
Technical Zone Approximate Level Interpretation
Immediate support $269.25 to $269.60 Recent intraday low area and first short-term support zone.
Key support $266.58 to $267.92 Reported pivot-support levels and a key area for preserving the current uptrend.
Secondary support $263.75 to $264.00 Prior support and possible deeper pullback zone.
Major support $260.60 to $261.70 13-week retracement and broader technical support zone.
Immediate resistance $272.56 to $273.90 Near-term pivot resistance and current supply zone.
Major resistance $275.23 to $275.55 Recent intraday high and third pivot-resistance zone.
52-week resistance $281.07 Annual high and major breakout-confirmation level.

Volume & Volatility Analysis

  • Volume: JNJ traded approximately 4.06 million shares on Sept. 25, below the reported average volume of about 7.17 to 7.24 million shares. Sept. 24 volume was approximately 6.16 to 6.32 million shares.
  • Volume-price relationship: Lighter volume during the pullback and consolidation suggests a lack of aggressive distribution. However, stronger volume would be needed to confirm a breakout above the $275 to $281 resistance zone.
  • Volatility: Volatility is low to moderate. The Sept. 25 daily range was approximately $2.99, or roughly 1.1% of the share price, consistent with a large-cap defensive stock in an orderly consolidation.
  • Options activity: The put/call volume ratio was reported near 0.61, indicating more calls than puts. This is modestly constructive, although it should be viewed as secondary to price and volume confirmation.
  • Current interpretation: Price is consolidating near highs with controlled volatility and lower volume. This supports a Stage 2 classification, but the stock needs a volume-backed breakout before it can be treated as a new momentum move.

Phase Classification

Stage 2: Accumulation Phase

  • Price action: JNJ remains near the upper end of its 52-week range and is holding a tight consolidation zone around $269 to $275.
  • Trend structure: The stock remains above its 200-day moving average and retains a constructive long-term uptrend, despite short-term resistance near $275 to $281.
  • Volume: Volume has been lighter during consolidation, which suggests controlled profit-taking rather than forceful distribution. The next upside move requires volume expansion for confirmation.
  • Volatility: Low to moderate, with contained daily ranges and no parabolic price expansion.
  • Momentum: Constructive but not extreme. The stock is near resistance but is not displaying the large, high-volatility bars typical of Stage 3.

Stage 2 is the most appropriate classification because JNJ is holding near highs with orderly consolidation and a favorable long-term trend. It is not Stage 3 because price expansion and volume remain controlled. A sustained high-volume move above $275.55 and then $281.07 would signal stronger momentum.

Pullback Risk

A decisive close below $266.58 to $267.92 on increasing volume would weaken the immediate accumulation structure and could expose JNJ to $263.75 to $264.00. A break below $260.60 to $261.70 would represent a more meaningful deterioration of the medium-term chart.

Final Summary & Recommended Action

Based on recent price action, volume, volatility and longer-term trend structure, JNJ is currently in Stage 2: Accumulation Phase.

Key Observations

  • Trend Direction: Gradual uptrend, with controlled consolidation near the upper end of the 52-week range.
  • Volume Behavior: Below average during the consolidation; no clear distribution signal, but a breakout requires stronger volume.
  • Volatility: Low to moderate, with daily ranges near 1% of price.
  • Immediate Support: $269.25 to $269.60.
  • Key Support: $266.58 to $267.92.
  • Immediate Resistance: $272.56 to $273.90.
  • Major Resistance: $275.23 to $275.55.
  • 52-Week Resistance: $281.07.

Suggested Strategy

  • Existing holders may continue holding while JNJ remains above $266.58 to $267.92, with a trailing stop or risk limit below that zone.
  • Fresh buyers should prefer controlled pullbacks toward $269.25 to $267.92 rather than chasing the stock near $275 to $281 resistance.
  • A sustained close above $275.55 with higher volume would offer the first breakout confirmation.
  • A move above $281.07 with expanding volume would provide stronger evidence of renewed momentum and possible Stage 3 characteristics.
  • A high-volume breakdown below $266.58 would favor reducing risk or waiting for stabilization near $263.75 to $264.00.
  • Monitor pharmaceutical trial results, regulatory developments, MedTech performance, litigation news, health care policy and broader defensive-sector rotation.

Final Action Plan

  • Current stance: HOLD / ADD ON PULLBACK.
  • Existing holders may continue holding while JNJ remains above $266.58 to $267.92.
  • Fresh buyers should favor a pullback toward $269.25 to $267.92 rather than entering near $275 to $281 resistance.
  • A high-volume breakout above $275.55 would support adding to a position.
  • A sustained move above $281.07 would confirm a new 52-week-high breakout and could signal a transition toward Stage 3 momentum.
  • A breakdown below $266.58 would weaken the accumulation structure and increase downside risk toward $263.75 to $264.00.

This analysis is educational and based on publicly reported market data available through Sept. 25, 2026. It is not investment advice. Confirm current price, volume and chart data before making a trading decision.